Another drug company has recalled a version of losartan blood pressure medication over concerns the drug contains tiny amounts of a carcinogen. Torrent Pharmaceuticals last week recalled eight more lots of losartan potassium tablets, on top of the two it recalled last month.
In a notice shared by the Food and Drug Administration, the India-based pharmaceutical company said the medication used to treat high blood pressure and diabetic kidney disease contained unacceptable levels of the human carcinogen N-nitrosodiethylamine.
The drugs contained an active ingredient made by Hetero Labs in India, one of two overseas factories linked to more than a dozen recalls of commonly prescribed blood pressure drugs since July.
From the FDA:
Adverse reactions or quality problems associated with the use of this product may be reported to FDA's MedWatch Adverse Event Reporting program either by phone, on line, by regular mail or by fax.